January 16, 2020

Disease Characteristics and Severity in Patients With Inflammatory Bowel Disease With Coexistent Diabetes Mellitus

Key Points

Key points are not available for this paper at this time.

Abstract

This study of a large IBD cohort suggests that DM in IBD may be associated with increased disease severity and that there may be room for increasing use of highly effective immunomodulator and/or biologic agents in this group.

Bookmark

Cite This Study

Din et al. (Thu,) studied this question.

synapsesocial.com/papers/69daa20185037e71b268437f https://doi.org/https://doi.org/10.1093/ibd/izz305

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Inflammatory Bowel Disease (IBD) pharmacotherapy and the risk of serious infection: a systematic review and network meta-analysis2017 · 57 citations
2Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance1993 · 7,446 citations
3Biologic Therapies and Risk of Infection and Malignancy in Patients With Inflammatory Bowel Disease: A Systematic Review and Network Meta-analysis2016 · 376 citations
4Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia2008 · 363 citations
5Risk for Overall Infection with Anti-TNF and Anti-integrin Agents Used in IBD2017 · 86 citations

Bookmark